Stories by Samer Fakhri

Samer Fakhri, MD, is an internationally recognized Otolaryngologist, Educator and Researcher who is currently an Associate Professor and residency Program Director at The University of Texas Medical School at Houston. He is the Principal Investigator on the first FDA approved study looking at the safety of autologous cord blood stem cells for the treatment of hearing loss. Dr. Fakhri received his medical degree from McGill University in Montreal, Canada. He completed his residency training at McGill University Health Center and pursued fellowship training in rhinology at the Cleveland Clinic Foundation. He also completed a research fellowship in Allergy and Immunology at the Meakins-Christie Laboratories of McGill University. Dr. Fakhri is certified by the American Board of Otolaryngology and the Royal College of Surgeons of Canada. He is a fellow of the American College of Surgeons, the Royal College of Surgeons of Canada, the American Academy of Otolaryngology-Head and Neck Surgery, and the American Rhinologic Society. He serves as a committee member of the American Rhinologic Society and contributes yearly instructional courses to the American Academy of Otolaryngology-Head and Neck Surgery. In addition he is on the editorial board and a reviewer for Otolaryngology journals. He is a frequently invited national and international panelist and speaker. Dr. Fakhri has numerous scientific articles and book chapters. Dr. Fakhri's areas of clinical interest include medical and surgical management of refractory chronic rhinosinusitis and sinonasal polyposis, image-guided surgery, endoscopic lacrimal and orbital surgery, CSF leak repair, and minimally invasive skull base surgery. Dr. Fakhri's areas of research interest include adult stem cell applications to hearing loss, mechanisms of upper airway inflammation and role of technology in advancing the care of patients with Otolaryngologic disorders.